JP2022510007A5 - - Google Patents

Info

Publication number
JP2022510007A5
JP2022510007A5 JP2021531637A JP2021531637A JP2022510007A5 JP 2022510007 A5 JP2022510007 A5 JP 2022510007A5 JP 2021531637 A JP2021531637 A JP 2021531637A JP 2021531637 A JP2021531637 A JP 2021531637A JP 2022510007 A5 JP2022510007 A5 JP 2022510007A5
Authority
JP
Japan
Prior art keywords
approximately
site
microneedle
skin
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021531637A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022510007A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/063351 external-priority patent/WO2020117564A1/en
Publication of JP2022510007A publication Critical patent/JP2022510007A/ja
Publication of JP2022510007A5 publication Critical patent/JP2022510007A5/ja
Priority to JP2024153896A priority Critical patent/JP2024170568A/ja
Pending legal-status Critical Current

Links

JP2021531637A 2018-12-03 2019-11-26 大型薬物の送達改善 Pending JP2022510007A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024153896A JP2024170568A (ja) 2018-12-03 2024-09-06 大型薬物の送達改善

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862774677P 2018-12-03 2018-12-03
US62/774,677 2018-12-03
US201962789407P 2019-01-07 2019-01-07
US62/789,407 2019-01-07
US201962808274P 2019-02-20 2019-02-20
US62/808,274 2019-02-20
PCT/US2019/063351 WO2020117564A1 (en) 2018-12-03 2019-11-26 Improved delivery of large agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024153896A Division JP2024170568A (ja) 2018-12-03 2024-09-06 大型薬物の送達改善

Publications (2)

Publication Number Publication Date
JP2022510007A JP2022510007A (ja) 2022-01-25
JP2022510007A5 true JP2022510007A5 (https=) 2022-12-05

Family

ID=68966029

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021531637A Pending JP2022510007A (ja) 2018-12-03 2019-11-26 大型薬物の送達改善
JP2024153896A Pending JP2024170568A (ja) 2018-12-03 2024-09-06 大型薬物の送達改善

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024153896A Pending JP2024170568A (ja) 2018-12-03 2024-09-06 大型薬物の送達改善

Country Status (12)

Country Link
US (1) US20220031595A1 (https=)
EP (1) EP3890704A1 (https=)
JP (2) JP2022510007A (https=)
KR (1) KR20210102301A (https=)
CN (2) CN113423381A (https=)
AU (2) AU2019391791A1 (https=)
BR (2) BR122023023068A2 (https=)
CA (1) CA3119043A1 (https=)
IL (1) IL283627A (https=)
MX (2) MX2021006102A (https=)
SG (1) SG11202104838SA (https=)
WO (1) WO2020117564A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019005833A (es) 2016-11-21 2019-10-30 Eirion Therapeutics Inc Administracion transdermica de agentes grandes.
US12599625B2 (en) 2021-05-13 2026-04-14 Penland Foundation Treatment of ARDS and other conditions caused by acutely elevated cytokine levels and post ARDS chronic cytokine production using inhaled anesthetics
WO2023287726A1 (en) 2021-07-12 2023-01-19 Penland Foundation Treatment of cancer using botulinum toxin and nitrous oxide
KR20230024669A (ko) * 2021-08-12 2023-02-21 주식회사 페로카 마이크로니들 패치
CN114191376B (zh) * 2022-01-05 2024-03-01 中国药科大学 一种用于治疗阿尔兹海默症的微针贴片及其制备方法

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US296006A (en) 1884-04-01 John hoefleb
US4270537A (en) 1979-11-19 1981-06-02 Romaine Richard A Automatic hypodermic syringe
CA1283827C (en) 1986-12-18 1991-05-07 Giorgio Cirelli Appliance for injection of liquid formulations
GB8704027D0 (en) 1987-02-20 1987-03-25 Owen Mumford Ltd Syringe needle combination
FR2638359A1 (fr) 1988-11-03 1990-05-04 Tino Dalto Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
US5008110A (en) 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5190521A (en) 1990-08-22 1993-03-02 Tecnol Medical Products, Inc. Apparatus and method for raising a skin wheal and anesthetizing skin
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
SE9102652D0 (sv) 1991-09-13 1991-09-13 Kabi Pharmacia Ab Injection needle arrangement
US7384918B2 (en) 1991-09-24 2008-06-10 Allergan, Inc. Botulinum toxin for treating muscle contracture
US6939852B2 (en) 1991-09-24 2005-09-06 Allergan, Inc. Methods and compositions for the treatment of cerebral palsy
US5328483A (en) 1992-02-27 1994-07-12 Jacoby Richard M Intradermal injection device with medication and needle guard
US6010715A (en) 1992-04-01 2000-01-04 Bertek, Inc. Transdermal patch incorporating a polymer film incorporated with an active agent
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
IT1261849B (it) 1993-09-02 1996-06-03 Avantgarde Spa Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
US5512547A (en) 1994-10-13 1996-04-30 Wisconsin Alumni Research Foundation Pharmaceutical composition of botulinum neurotoxin and method of preparation
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
IT1298087B1 (it) 1998-01-08 1999-12-20 Fiderm S R L Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
US5965154A (en) 1998-03-17 1999-10-12 Plc Holding, L.L.C. Adhesive matrix type transdermal patch and method of manufacturing same
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US6611707B1 (en) 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
US6306423B1 (en) 2000-06-02 2001-10-23 Allergan Sales, Inc. Neurotoxin implant
US6908453B2 (en) 2002-01-15 2005-06-21 3M Innovative Properties Company Microneedle devices and methods of manufacture
US20040009180A1 (en) 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
MX2007010674A (es) 2005-03-03 2007-11-08 Revance Therapeutics Inc Composiciones y metodos para la aplicacion topica y el suministro transdermico de un oligopeptido.
WO2007098057A2 (en) * 2006-02-17 2007-08-30 Zogenix, Inc. Method and system for delivery of neurotoxins
US8658391B2 (en) 2006-04-27 2014-02-25 Anterios, Inc. Assessment of the effects of topical administration of chemodenervating pharmaceuticals
US20120150023A1 (en) 2007-08-06 2012-06-14 Kaspar Roger L Microneedle arrays for active agent delivery
KR101848095B1 (ko) * 2008-06-26 2018-04-11 안테리오스, 인코퍼레이티드 경피 운반
US20100196445A1 (en) 2008-11-12 2010-08-05 David Nathaniel E Systems and methods for delivery of biologically active agents
BRPI0916150B1 (pt) * 2008-11-18 2019-09-24 3M Innovative Properties Company Arranjo de microagulhas ocas
HUE037595T2 (hu) 2008-12-31 2018-09-28 Revance Therapeutics Inc Injektálható botulinum toxin készítmények
WO2011151723A2 (en) * 2010-06-01 2011-12-08 Novartis Ag Concentration of vaccine antigens without lyophilization
US20120328701A1 (en) 2011-01-24 2012-12-27 Anterios, Inc. Nanoparticle compositions, formulations thereof, and uses therefor
BR112013018918A2 (pt) 2011-01-24 2016-10-04 Anterios Inc composições de nanopartículas
US9144671B2 (en) 2011-12-21 2015-09-29 3M Innovative Properties Company Transdermal adhesive patch assembly with removable microneedle array and method of using same
US9254314B2 (en) * 2013-11-12 2016-02-09 Eric Finzi Treatment of social anxiety disorder, obsessive compulsive disorder and panic disorder using botulinum toxin
US9943576B2 (en) * 2014-04-30 2018-04-17 Allergan, Inc. Formulations of biologics for intravesical instillation
US20170209553A1 (en) * 2016-01-22 2017-07-27 Transderm, Inc. Delivery of botulinum with microneedle arrays
KR20190123256A (ko) * 2016-07-29 2019-10-31 로저 엘. 카스파 액취증 치료 방법
MX2019005833A (es) * 2016-11-21 2019-10-30 Eirion Therapeutics Inc Administracion transdermica de agentes grandes.
CN107320841A (zh) * 2017-08-03 2017-11-07 党明 一种高分子微针及其制备方法和应用

Similar Documents

Publication Publication Date Title
JP2022510007A5 (https=)
JP2022164750A5 (https=)
JP2019535829A5 (https=)
US7507419B2 (en) Topically applied Clostridium botulinum toxin compositions and treatment methods
DE60104686T2 (de) Applikator mit auf einer schleiffende oberfläche überzogene substanz zum auftragen auf haut
US11311496B2 (en) Transdermal delivery of large agents
JP2005538082A5 (https=)
IL168745A0 (en) Compositions comprising botulinum toxin and a human serum albumin, method for producing the same and use thereof in the preparation of medicaments
WO2012103039A1 (en) Surfactant compositions
WO2000074703A2 (de) Therapeutikum mit einem botulinum-neurotoxin
US20220031595A1 (en) Improved delivery of large agents
JP2022533113A5 (https=)
JP2025118791A (ja) ピーク効果の遅延および／または応答持続時間の延長
DE10103158A1 (de) Vorrichtung zur elektrisch unterstützen Abgabe von Wirkstoffen aus flächenförmigen therapeutischen Systemen
HK40110119A (zh) 大试剂的透皮递送
US20240189577A1 (en) Methods and devices for directing dissipation of a charged active agent after administration
HK40070640A (en) Delaying peak effect and/or extending duration of response
HK40060152A (en) Improved delivery of large agents
HK40013656A (en) Transdermal delivery of large agents
BR112019010131B1 (pt) Composição de nanoemulsão, emplastro, kit e uso de um agente grande que tem um peso molecular de 100.000 da ou maior no condicionamento da pele e para tratar distúrbios dermatológicos
BR122025013906A2 (pt) Composição de agentes grandes, emplastro, kit e seus usos transdérmicos